Article
Mutant p53 in head and neck squamous cell carcinoma: Molecular mechanism of gain‑of‑function and targeting therapy (Review).
Oncology reports - 1 Sept 2023
Li Minmin, Sun Dongyuan, Song Ning, Chen Xi, Zhang Xinyue, Zheng Wentian, Yu Yang, Han Chengbing
Abstract excerpt
Head and neck squamous cell carcinoma (HNSCC) is one of the most widespread malignancies worldwide. p53, as a transcription factor, can play its role in tumor suppression by activating the expression of numerous target genes. However, p53 is one of the most commonly mutated genes, which frequently harbors missense mutations. These missense mutations are nucleotide substitutions that result in the substitution of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
